Hoffmann-La Roche: all 2,744 studies
Page 24 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Single Ascending And Multiple Ascending Dose Study of RO5271983 in Healthy VolunteersCompletedNCT01209221Phase 1
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's LymphomaCompletedNCT01209130Phase 1
- Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2Active, not recruitingNCT01208389Phase 1/2
- A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial TumorsCompletedNCT01207323Phase 1
- An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)CompletedNCT01200225
- A Study of RO5310074 in Patients With Psoriatic ArthritisCompletedNCT01199809Phase 1
- An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)TerminatedNCT01196780
- A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State MemantineCompletedNCT01196065Phase 1
- A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)CompletedNCT01196039Phase 2
- An Observational Study on Long-Term Effectiveness and Safety of RoActemra/Actemra (Tocilizumab) in Daily Practice in Patients With Rheumatoid Arthritis (ICHIBAN)Status unknownNCT01194401
- An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung CancerCompletedNCT01194050
- A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)CompletedNCT01192906Phase 3
- A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of SchizophreniaCompletedNCT01192880Phase 3
- A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)CompletedNCT01192867Phase 3
- A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic NephropathyCompletedNCT01191983Phase 4
- A Study of Aleglitazar in Combination With Ibuprofen in Healthy VolunteersCompletedNCT01188317Phase 1
- A Study of Aleglitazar in Combination With Aspirin in Healthy VolunteersCompletedNCT01188304Phase 1
- Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerCompletedNCT01186991Phase 2
- A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic ImpairmentCompletedNCT01185873Phase 1
- A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1CompletedNCT01185860Phase 1
- A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT01185847Phase 2
- A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra TreatmentCompletedNCT01183598Phase 1
- A Study of RO4917838 With Rosuvastatin in Healthy VolunteersCompletedNCT01183585Phase 1
- A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1CompletedNCT01181024Phase 1
- A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.WithdrawnNCT01179594Phase 4
- A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female SubjectsCompletedNCT01173536Phase 1
- A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of AgeCompletedNCT01165580Phase 1
- A Study of RO5190591 (Danoprevir) in Healthy VolunteersCompletedNCT01164488Phase 1
- A Study of RO5045337 in Patients With Solid TumorsCompletedNCT01164033Phase 1
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic RhinitisCompletedNCT01160861Phase 1
- A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell CarcinomaApproved for marketingNCT01160250
- A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)WithdrawnNCT01156961Phase 4
- A Study of RO5024048 in Japanese and Caucasian Healthy VolunteersCompletedNCT01152671Phase 1
- A Study of RO4989991 in Patients With Allergic RhinitisCompletedNCT01152619Phase 1
- A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinCompletedNCT01152606
- A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian CancerCompletedNCT01148758Phase 1
- A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid TumorsCompletedNCT01143753Phase 1
- A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking SurgeryCompletedNCT01143740Phase 1
- A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerCompletedNCT01142778Phase 2
- A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid TumorsCompletedNCT01139723Phase 1
- Accu-Chek missiOn: SMBG in Patients With diAbetes on inSulin Study (COMPASS) - Multiple Center, Open, and Non-randomized StudyCompletedNCT01130480Not applicable
- A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal OsteoporosisCompletedNCT01128257
- A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple MyelomaCompletedNCT01122875Phase 1
- A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast CancerNo longer availableNCT01120561
- A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR)TerminatedNCT01117129Phase 4
- A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective DisorderCompletedNCT01116830Phase 1
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01106599Phase 1
- An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal AnemiaCompletedNCT01105494
- A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048CompletedNCT01099904Phase 1
- A Study of Balapiravir in Patients With Dengue Virus InfectionCompletedNCT01096576Phase 1
- A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid TumorsCompletedNCT01090960Phase 1
- A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.CompletedNCT01088659Phase 3
- A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)CompletedNCT01087151Phase 2
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedNCT01086085Phase 4
- A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) ProgressionCompletedNCT01077726Phase 2
- An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)CompletedNCT01075477
- A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01075464Phase 1
- An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01072240
- An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung CancerCompletedNCT01070927Phase 2
- A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT01068977Phase 1
- A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01066884Phase 4
- A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4CompletedNCT01057667Phase 2
- A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination TherapyTerminatedNCT01051011Phase 3
- Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus CalculatorsCompletedNCT01050868Not applicable
- A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01046266Phase 1
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy VolunteersCompletedNCT01045083Phase 1
- A Study of Single Doses of RO4998452 in Patients With Type 2 DiabetesCompletedNCT01044017Phase 1
- A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentCompletedNCT01043029Phase 2
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusCompletedNCT01042769Phase 3
- A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) InfectionCompletedNCT01022346Phase 2
- A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular DiseaseCompletedNCT01018173Phase 3
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.CompletedNCT01017302Phase 1
- A Study With RO4917523 in Patients With Fragile X SyndromeCompletedNCT01015430Phase 2
- A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary DiseaseWithdrawnNCT01009424Phase 1
- A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy VolunteersCompletedNCT00999128Phase 1
- A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy VolunteersCompletedNCT00997919Phase 1
- A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing PotentialCompletedNCT00991718Phase 1
- A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid TumorsTerminatedNCT00985374Phase 1
- A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic AsthmaCompletedNCT00983658Phase 2
- Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionCompletedNCT00978497Phase 2
- A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic MalignanciesTerminatedNCT00977067Phase 1
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)CompletedNCT00976170Phase 1
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid TumorsCompletedNCT00975182Phase 1
- A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00974584Phase 1
- A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic AtrophyCompletedNCT00973011Phase 1
- A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled CorticosteroidsCompletedNCT00971035Phase 2
- A Study of RO5036505 in Patients With Moderate to Severe AsthmaWithdrawnNCT00967590Phase 2
- A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT00965653Phase 1
- A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerWithdrawnNCT00964704Phase 2
- A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus InfectionCompletedNCT00963885Phase 2
- A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous StudiesCompletedNCT00962975Phase 1
- A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus ErythematosusCompletedNCT00962832Phase 2
- A Study of RO5095932 in Patients With Type 2 Diabetes MellitusCompletedNCT00961909Phase 1
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast CancerCompletedNCT00960960Phase 1
- A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00954642Phase 1
- A Study of Xenical (Orlistat) in Overweight and Obese AdolescentsCompletedNCT00940628Phase 3
- A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis CCompletedNCT00940420Phase 4
- OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00940303Phase 2
- A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal ImpairmentCompletedNCT00933972Phase 1
- A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular LymphomaCompletedNCT00930514Phase 1